Related Articles by Review for PMID: 12579092

Year	Number of Results
1985	1
1988	1
1990	1
1994	5
1995	1
1997	3
1998	2
1999	6
2000	6
2001	4
2002	4
2003	7
2004	2
2005	4
2006	1
2007	2
2008	2
2009	2
2010	5
2011	2
2012	2
2013	4
2014	4
2015	2
2016	1
2017	3
2018	1
2019	1
2020	2
2021	2
2022	2
2024	0

1

Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.

Lord RV, Park JM, Wickramasinghe K, DeMeester SR, Oberg S, Salonga D, Singer J, Peters JH, Danenberg KD, Demeester TR, Danenberg PV. Lord RV, et al. J Thorac Cardiovasc Surg. 2003 Feb;125(2):246-53. doi: 10.1067/mtc.2003.203. J Thorac Cardiovasc Surg. 2003. PMID: 12579092 Free article.

2

The molecular biology of esophageal adenocarcinoma.

Koppert LB, Wijnhoven BP, van Dekken H, Tilanus HW, Dinjens WN. Koppert LB, et al. J Surg Oncol. 2005 Dec 1;92(3):169-90. doi: 10.1002/jso.20359. J Surg Oncol. 2005. PMID: 16299787 Review.

3

Expression of eIF4E during head and neck tumorigenesis: possible role in angiogenesis.

Nathan CO, Franklin S, Abreo FW, Nassar R, de Benedetti A, Williams J, Stucker FJ. Nathan CO, et al. Laryngoscope. 1999 Aug;109(8):1253-8. doi: 10.1097/00005537-199908000-00013. Laryngoscope. 1999. PMID: 10443829 Review.

4

Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.

Shaheen NJ, Spechler SJ. Shaheen NJ, et al. Endoscopy. 2008 Dec;40(12):994-9. doi: 10.1055/s-2008-1077785. Epub 2008 Dec 8. Endoscopy. 2008. PMID: 19065482 Review. No abstract available.

5

[Barrett esophagus and Barrett carcinoma].

Kruyt PH, van Sandick JW, van Lanschot JJ, Offerhaus GJ, Tytgat GN, Obertop H. Kruyt PH, et al. Ned Tijdschr Geneeskd. 1997 May 3;141(18):869-73. Ned Tijdschr Geneeskd. 1997. PMID: 9273450 Review. Dutch.

6

Barrett esophagus: diagnostic challenges.

Hagen CE, Lauwers GY, Mino-Kenudson M. Hagen CE, et al. Semin Diagn Pathol. 2014 Mar;31(2):100-13. doi: 10.1053/j.semdp.2014.02.005. Epub 2014 Feb 12. Semin Diagn Pathol. 2014. PMID: 24815936 Review.

7

Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus.

Sarbia M, Arjumand J, Wolter M, Reifenberger G, Heep H, Gabbert HE. Sarbia M, et al. Am J Clin Pathol. 2001 Jun;115(6):835-40. doi: 10.1309/MXXH-25N3-UAL2-G7XX. Am J Clin Pathol. 2001. PMID: 11392879 Review.

8

A clinical and histopathologic focus on Barrett esophagus and Barrett-related dysplasia.

Voltaggio L, Montgomery EA, Lam-Himlin D. Voltaggio L, et al. Arch Pathol Lab Med. 2011 Oct;135(10):1249-60. doi: 10.5858/arpa.2011-0019-RA. Arch Pathol Lab Med. 2011. PMID: 21970480 Free article. Review.

9

[Barrett carcinoma as a tumor entity with special therapy consequences].

Fuchs KH. Fuchs KH. Langenbecks Arch Chir Suppl Kongressbd. 1998;115:295-9. Langenbecks Arch Chir Suppl Kongressbd. 1998. PMID: 9931628 Review. German.

10

Controversies in Barrett esophagus.

Dunbar KB, Spechler SJ. Dunbar KB, et al. Mayo Clin Proc. 2014 Jul;89(7):973-84. doi: 10.1016/j.mayocp.2014.01.022. Epub 2014 May 24. Mayo Clin Proc. 2014. PMID: 24867396 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year